Apomorphine in treatment of Parkinson's disease: comparison between subcutaneous and sublingual routes.
Open Access
- 1 January 1993
- journal article
- research article
- Published by BMJ in Journal of Neurology, Neurosurgery & Psychiatry
- Vol. 56 (1) , 101-103
- https://doi.org/10.1136/jnnp.56.1.101
Abstract
The efficacy of two routes of apomorphine, subcutaneous (SC) and sublingual (SL), successively administered in 7 Parkinsonian patients with motor fluctuations, was compared in reducing the daily duration of "off" phases. The mean duration of SC and SL treatment was 7.7 and 6.8 months respectively. The mean time spent in "off" phase was 55% after SC and 68% after SL treatment. The mean time before turning "on" after an "off" period was 14 minutes after SC and 28 minutes after SL treatment. Two patients developed stomatitis after SL route. SL apomorphine may be helpful in the treatment of motor fluctuations in PD.Keywords
This publication has 9 references indexed in Scilit:
- Sublingual Apomorphine in the Treatment of Parkinsonʼs Disease Complicated by Motor FluctuationsClinical Neuropharmacology, 1991
- Sublingual Apomorphine in Parkinsonʼs DiseaseClinical Neuropharmacology, 1991
- Intranasal apomorphine in Parkinson's diseaseNeurology, 1991
- Absorption of apomorphine by various routes in parkinsonismMovement Disorders, 1991
- Subcutaneous apomorphine in the treatment of Parkinson's disease.Journal of Neurology, Neurosurgery & Psychiatry, 1990
- SUBCUTANEOUS APOMORPHINE ADMINISTRATION IN PARKINSONIAN MOTOR FLUCTUATIONS1990
- Sublingual apomorphine and Parkinson's disease.Journal of Neurology, Neurosurgery & Psychiatry, 1989
- SUBCUTANEOUS APOMORPHINE IN PARKINSON'S DISEASEThe Lancet, 1988
- SUBCUTANEOUS APOMORPHINE IN PARKINSONIAN ON-OFF OSCILLATIONSThe Lancet, 1988